Discontinued — last reported Q4 '21
Thermo Fisher Scientific Debt Issuance Costs, Net increased by 18.0% to $229.00M in Q1 2026 compared to the prior quarter.
Higher balances indicate recent significant debt issuance activity; the amortization schedule impacts interest expense.
Costs incurred in connection with the issuance of debt, such as underwriting fees and legal expenses, which are capitali...
Standard for all capital-intensive firms; proportional to the total amount of outstanding debt.
other_deferred_finance_costs_net| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $194.00M | $229.00M |
| QoQ Change | — | +18.0% |